057 The role of substance P and its receptor NK1R in chronic prurigo: Results from a randomized, controlled trial with topical aprepitant
Journal of Investigative Dermatology2017Vol. 137(10), pp. S202–S202
Tatevik Ohanyan, Nicole Schoepke, Stefan Eirefelt, Gert Van Hoey, Witte Koopmann, Tomasz Hawro, Marcus Maurer, Martin Metz
Related Papers
- → A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor(1991)864 cited
- → Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography(2019)58 cited
- → Neurokinin-1 receptor antagonists: a comprehensive patent survey(2010)57 cited
- → Aprepitant: A novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma(2012)20 cited
- → Computational Analysis of the Neurokinin-1 Receptor Interactions with Antagonists(2021)